News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Centene handily beat Wall Street's expectations in the second quarter, as higher revenue from premiums and rate hikes for the managed care …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%(RTTNews) - Centene Corporation (CNC) will host a conference call at 8:30 AM ET on July 28, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.centene.com/events-presentations To listen to the call, dial 1-877-883-0383 (US) or +1-412-902-6506 (International), …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene (CNC) came out with quarterly earnings of $2.51 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to a loss of $0.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene's (NYSE:CNC) Q2 CY2026: Strong Sales, Guides for Strong Full-Year Sales Health coverage company Centene (NYSE:CNC) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 9.9% year on year to $53.58 billion. The company's full-year revenue guidance of $195.5 billion …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene Corp. has raised its annual profit guidance following better-than-expected second-quarter results. The US health insurer now anticipates adjusted earnings greater than $4.80 a share, an increase from its previous forecast of over $3.40. This positive outlook is supported by medical expenses that were …
This article provides a brief earnings snapshot for Centene's Q2 performance. It contains no specific financial details or further information beyond the headline.
ST. LOUIS, July 28, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that Kenneth A. Burdick has retired from the Company's Board of Directors, effective July 28, 2026, and that Paul J. Diaz has been appointed to the Board, effective July 28, 2026.Centene …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%-- Second Quarter GAAP Diluted Earnings Per Share of $2.19; Adjusted Diluted Earnings Per Share of $2.51 -- -- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.11 & Adjusted Diluted EPS Greater than $4.80 -- Commercial HBR of 79.2%, demonstrating significant year-over-year improvement …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene (CNC) reported strong second-quarter fiscal 2026 results, significantly beating analyst estimates for both revenue and adjusted diluted EPS. The managed-care company posted $2.51 adjusted diluted EPS on $53.58 billion in revenue, leading to an upward revision of its full-year guidance. Shares reacted positively, …
For the quarter ended June 2026, Centene (CNC) reported revenue of $53.58 billion, up 9.9% over the same period last year. EPS came in at $2.51, compared to -$0.16 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $47.53 …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene Corp. is set to report second-quarter earnings, with investors closely watching Medicaid margin trends and sustainability given normalizations in enrollment. Analysts expect earnings of $1.08 per share on $47.64 billion in revenue, with a focus on state-level dynamics and profitability in the Affordable …
This article provides a comprehensive income statement for Centene Corp (CNC), offering detailed quarterly and annual financial data. It covers key metrics such as total revenue, cost of revenue, operating expenses, operating profit, net non-operating interest income/expenses, special income/expenses, other non-operating income/expenses, income before …
This article details the shareholder structure of Centene Corp (CNC), outlining its major shareholders and institutional holdings. It provides a breakdown of proportional ownership by investment advisors, hedge funds, and other investor types, alongside a historical view of institutional shareholding and recent shareholder activity …
Centene Corp. (ISIN US15133V1035) stock remains stable as investors focus on its strong Medicaid and government health contracts. The company reported roughly $156 billion in revenue for fiscal year 2024 and provided guidance for approximately $160 billion in 2025, highlighting its reliance on membership …
This article provides a detailed financial overview of Centene Corp (CNC), including its stock performance, key financial indicators like EPS, revenue, net profit, and margins across quarterly and annual periods. It highlights financial statements such as the income statement, balance sheet, and cash flow …
Centene Corp. reported strong financial results for 2025, with $163.1 billion in premium and service revenues and adjusted diluted EPS of $7.11. The company's large membership base of 28.7 million, primarily driven by government-sponsored programs like Medicaid, anchors its financial performance. Centene's medical cost …
Centene Corp. (US15133V1035) is facing earnings pressure due to Medicaid redeterminations, exchange membership, and recent operating metrics. The article emphasizes that for investors, the relationship between growth and margins is crucial, as even minor shifts in medical loss ratio or enrollment mix can significantly …
In its upcoming report, Centene (CNC) is predicted by Wall Street analysts to post quarterly earnings of $0.89 per share, reflecting an increase of 656.3% compared to the same period last year. Revenues are forecasted to be $47.53 billion, representing a year-over-year decrease of …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene Corp. (ISIN US15133V1035) reported multi-billion-dollar revenue and higher earnings guidance for 2024, supported by growth in its marketplace and Medicare Advantage businesses. The company is navigating Medicaid redeterminations by shifting members to marketplace products, which, along with cost controls and improved profitability in …
Centene's stock is showing stability as its Medicaid and marketplace membership base recovers following the redetermination cycle. The company has navigated membership shifts, demonstrating efforts to align with 2025 guidance and improve margin trends through operational efficiencies and strategic investments. Investors are closely watching …
Cognizant has reportedly secured a mega deal with Centene, a healthcare company, valued at over $500 million. This significant contract underscores Cognizant's continued presence and success in securing large-scale projects within the healthcare sector.
Cognizant has secured a multi-year technology services deal with US health insurer Centene Corp, reportedly worth between $500 million and $1 billion. This agreement is expected to significantly bolster Cognizant's healthcare business by leveraging its TriZetto platform and new AI frameworks like Agentic AI. …
Cognizant has secured a multi-year technology services contract worth over $500 million, potentially reaching $1 billion, from US health insurer Centene Corp. This deal reinforces Cognizant's position in the healthcare technology market and highlights CEO Ravi Kumar's strategy to expand the company's AI-led healthcare …
Cognizant has secured a multi-year technology services deal from US health insurer Centene Corp, reportedly worth over $500 million and potentially up to $1 billion. This deal marks a significant win for Cognizant, especially as Centene had previously restructured a major agreement with them …
Institutional investors significantly increased their positions in Centene Corp. (CNC) according to recent 13F filings, indicating strong "smart money" buying activity. Notable investors like Bill Nygren, Cliff Asness, David Einhorn, and Steve Cohen (who initiated a new position) purchased shares, suggesting conviction in Centene's …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene Corporation (NYSE: CNC) director Lauren M. Tyler was granted 3,155 restricted stock units on July 17, 2026, as equity compensation. These units are set to vest in full on the date of the company's 2027 annual meeting of stockholders, increasing Tyler's direct holdings …
Centene Corp. is navigating the complexities of Medicaid redeterminations and marketplace enrollment while also growing its Medicare business, as highlighted by its 2025 results and 2026 guidance. The company's revenue growth is supported by government programs, with marketplace expansion helping to offset some impacts …
Centene stock's recent performance is influenced by its strong presence in Medicaid and Affordable Care Act marketplaces, alongside disciplined cost control. The company, a major US managed care provider, focuses on government-sponsored health plans and aims to simplify its structure while managing the complexities …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Centene (CNC) stock rose 3.2% today, primarily driven by a broader rebound in managed-care stocks after an industry peer exceeded quarterly results and raised its 2026 outlook. Additionally, Centene secured an Illinois Medicaid contract and anticipates its Q2 2026 earnings release on July 28, …
Centene Corp. (US15133V1035) remains a key managed-care company, with its latest Q1 2026 earnings revealing $41.4 billion in premium and service revenue, $2.90 adjusted diluted EPS, and 28.3 million members. These figures provide a strong fundamental baseline for its stock, primarily driven by government-sponsored …
Arkansas's Medicaid expansion program, ARHOME, faces challenges as one of its main insurance providers, Centene Corp., is withdrawing in 2027 due to funding issues. The state, a pioneer in hybrid expansion models and work requirements, is also preparing for new federal mandates that will …
Centene (CNC) has received a modest fair value uplift from US$61.83 to US$63.78, reflecting analysts' more constructive view on its earnings power. While some analysts are bullish due to favorable trends in exchanges, Medicare Advantage, and Medicaid margin recovery, others maintain neutral ratings due …
Sharemaestro market context Trend signal active 52 weeks +110.3% · Next-week setup negative 32.1%Search by ticker symbol or company name and select a result to open its chart.